529-21-5 Usage
Description
3-Ethyl-4-methylpyridine, a member of the pyridine family, is a chemical compound with the formula C8H11N. It features a six-membered ring composed of five carbon atoms and one nitrogen atom, with an ethyl and a methyl group attached to the pyridine ring. Known for its distinct odor, this compound is utilized in various applications, including organic synthesis, flavorings, fragrances, and pharmaceuticals, making it a subject of interest for researchers and chemists.
Uses
Used in Organic Synthesis:
3-Ethyl-4-methylpyridine serves as a building block in organic synthesis, contributing to the creation of a wide range of organic compounds due to its versatile chemical structure.
Used in Flavor and Fragrance Industry:
Leveraging its distinct odor, 3-Ethyl-4-methylpyridine is used in the production of flavorings and fragrances, adding unique scents and tastes to various consumer products.
Used as a Precursor in Pharmaceutical Synthesis:
3-ETHYL-4-METHYLPYRIDINE also acts as a precursor in the synthesis of pharmaceuticals, playing a crucial role in the development of new medications and contributing to advancements in healthcare.
Used in Research and Development:
3-Ethyl-4-methylpyridine is of interest to researchers and chemists who study its properties and potential uses, further expanding its applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 529-21-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,2 and 9 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 529-21:
(5*5)+(4*2)+(3*9)+(2*2)+(1*1)=65
65 % 10 = 5
So 529-21-5 is a valid CAS Registry Number.
529-21-5Relevant articles and documents
Inhibitors of cell proliferation, angiogenesis, fertility, and muscle contraction
-
, (2008/06/13)
The invention concerns inhibitors of cell proliferation, angiogenesis, fertility, and muscle contraction, characterized by formula I wherein, X, Y and Z independently represent C or N; ------ is an optional double bond; n is 0 or 1; R1, R2, and R4 independently represent hydrogen, a chemical bond, C1-10 alkyl; C2-10 alkenyl; C2-10 alkinyl; aryl; aryl-C1-10 alkyl; C3-10 heterocyclyl; C5-10 heteroaryl; halo, CF3; NO2; NHC(O)R*, OR, said alkyl, alkenyl, alkinyl, aryl, arylalkyl, heterocyclyl, or heteroaryl being optionally substituted; R3, R5, and R6 independently represent hydrogen, C1-10alkyl; C2-10 alkenyl; C2-10 alkinyl; aryl; aryl-C1-10alkyl; C3-10 heterocyclyl; C5-10 heteroaryl; halo, CF3; NO2; NHC(O)R*, OR, said alkyl, alkenyl, alkinyl, aryl, heterocyclyl, or heteroaryl being optionally substituted; or R5 and R6 together form a 5- or 6-member aryl, heterocyclyl or heteroaryl group; R is hydrogen or C1-6 alkyl; R* is hydrogen, or C1-6 alkyl, or OH, wherein the optional substituents are preferably selected from the group of one to three OH, C1-6 alkyl, halo, NO2, C1-6 alkoxy, and CF3, or a pharmaceutically acceptable salt thereof.
Catalytic reactions of pyridines. VI. Heterogeneous vapor-phase ring alkylation of pyridines with alcohols over H+-, Li+-, and alkaline earth cation-exchanged zeolites
Kashiwagi,Fujiki,Enomoto
, p. 2575 - 2578 (2007/10/02)
-
